Article

Florida Cancer Specialists, Cigna Expand Collaboration to All Cancer Types

Author(s):

A 28% reduction in hospital admissions leads to a broader agreement, the physicians' group and payer say.

Florida Cancer Specialists and Research Initiative (FCS) and the insurer Cigna are expanding their collaboration for value-based cancer care. Since 2015, FCS has provided services to Cigna patients through a collaborative care arrangement that included extra support, education, and efforts to reduce hospitalization and unnecessary visits to the emergency department.

Those efforts were initially offered to patients with breast, lung, and colorectal cancers, leukemia, and lymphoma and resulted in a 28% lower inpatient admission rate compared with patients outside the value-based model. So now, the collaboration will involve patients with all cancer diagnoses and provide additional treatment therapies.

For more, see the full press release here.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Screenshot of Coral Omene, MD, PhD
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
ASCO 2025
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Dr Margrit Wiesendanger
Ibrahim Aldoss, MD, associate professor, City of Hope
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
Cathy Eng, MD, FACP, FASCO
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo